Text Size

Association of systemic comorbidities with dry eye disease

Kawashima M., Yamada M., Shigeyasu C., Suwaki K., Uchino M., Hiratsuka Y., Yokoi N., Tsubota K., DECS-J Study Group


  • 2020
  • Journal of Clinical Medicine
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Ophthalmology, Keio University School of Medicine, Tokyo, 1608582, Japan; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, 1818611, Japan; Department of Japan Medical Affairs, Santen Pharmaceutical Co., Ltd, Osaka, 5308552, Japan; Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, 1138431, Japan; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, 6020841, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022